Jnana Therapeutics Inc. is a precision medicine company headquartered in Boston, Massachusetts, launched in 2017 to develop novel therapeutics.
Subscribe to see Jnana Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Jnana Therapeutics Inc. is a therapeutics company headquartered in Boston, United States, founded in 2016. It has raised at least $364M across the 5 funding rounds on record. Its most recent funding round, Series C, raised $107M in November 2022. Xcout tracks 11 named people at Jnana Therapeutics Inc., including George Vratsanos (President CEO).
As of 16 November 2026. Source: Xcout Intel.
5 more named people on record for Jnana Therapeutics Inc., with roles, board committees and tenure — see the full roster →
At least $364M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $107M | 10 named | |
| Series C-1 | $107M | 6 named | |
| SEC Form D filing | $50M | 6 named | |
| Series B | $50M | 10 named | |
| Series A | $50M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 8 named investors across 5 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Jnana Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Frontier Medicines, Corp. is a precision medicine company focusing on drug development with offices in locations including South San Francisco, California, and Boston.
Samsara Therapeutics Inc. is a platform biotechnology startup engaged in the discovery and development of compounds that address primary health conditions.
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Jnana Therapeutics Inc.? Suggest a correction · Work at Jnana Therapeutics Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.